Zurich, 23 October 2025. Elixion Biotech emerges from stealth, announcing the in-silico validation of five targets via its ...

The gap between lab measurements and real-world applications can lead to suboptimal socket selection and hidden quality risks for customers.

Validating drug production processes need not be a headache, according to AI researchers who say machine learning (ML) could be a single answer to biopharma’s multivariate problem. The FDA defines ...